Kinga Matuła is the CEO and co-founder of QurieGen. With over ten years of experience in research at the intersection of chemistry, biology, and physics, Kinga is passionate about turning scientific discoveries into tangible impacts. As a former oncological patient, she is deeply committed to bridging the gap between innovation and patients. Kinga has received startup business development training from various programs, including the Silicon Valley Draper Hero Program. Under her leadership, QurieGen won the Venture Challenge (May 2022) and received a Golden Ticket to Silicon Valley's prestigious 5-week accelerator program (July 2022), placing 2nd in Demo Day led by Tim Draper (selected out of 55 companies from 27 countries).